These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11195286)

  • 1. Recent advances in the adjuvant therapy of breast cancer.
    Di Leo A
    Tumori; 2000; 86(5 Suppl 1):S11-3. PubMed ID: 11195286
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH recommends range of adjuvant breast cancer therapies.
    Cancer Pract; 2001; 9(2):57. PubMed ID: 11879275
    [No Abstract]   [Full Text] [Related]  

  • 3. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis.
    Zavyalova MV; Perelmuter VM; Vtorushin SV; Denisov EV; Litvyakov NV; Slonimskaya EM; Cherdyntseva NV
    Diagn Cytopathol; 2013 Mar; 41(3):279-82. PubMed ID: 22102485
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative image analysis of estrogen and progesterone receptors as a prognostic tool for selecting breast cancer patients for therapy.
    Castagnetta LA; Traina A; Liquori M; Marasà L; Amodio R; Di Falco M; Miele M; Rausa L; Carruba G
    Anal Quant Cytol Histol; 1999 Feb; 21(1):59-62. PubMed ID: 10068777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
    Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
    Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
    Goldhirsch A; Glick JH; Gelber RD; Coates AS; Senn HJ
    J Clin Oncol; 2001 Sep; 19(18):3817-27. PubMed ID: 11559719
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Youth and hormone receptors in breast cancer: good or bad news first?
    Stockler M; Beith J
    Lancet; 2000 May; 355(9218):1839-40. PubMed ID: 10866433
    [No Abstract]   [Full Text] [Related]  

  • 9. Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study.
    de Glas NA; Fontein DB; Bastiaannet E; Pijpe A; De Craen AJ; Liefers GJ; Nortier HJ; de Haes HJ; van de Velde CJ; van Leeuwen FE
    Cancer; 2014 Sep; 120(18):2847-54. PubMed ID: 24840230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
    Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
    Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.
    Colleoni M; Munzone E
    Drugs; 2015 Aug; 75(12):1311-21. PubMed ID: 26177891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women.
    Seidman AD
    Oncology (Williston Park); 2016 Mar; 30(3):224-8. PubMed ID: 26984215
    [No Abstract]   [Full Text] [Related]  

  • 13. TAILORx: trial assigning individualized options for treatment (Rx).
    Sparano JA
    Clin Breast Cancer; 2006 Oct; 7(4):347-50. PubMed ID: 17092406
    [No Abstract]   [Full Text] [Related]  

  • 14. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
    Dartois L; Fagherazzi G; Baglietto L; Boutron-Ruault MC; Delaloge S; Mesrine S; Clavel-Chapelon F
    Int J Cancer; 2016 May; 138(10):2415-27. PubMed ID: 26756677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance.
    Corte MD; Tamargo F; Alvarez A; Rodríguez JC; Vázquez J; Sánchez R; Lamelas ML; González LO; Allende MT; García-Muñiz JL; Fueyo A; Vizoso F
    Breast Cancer Res Treat; 2006 Mar; 96(1):63-72. PubMed ID: 16267614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
    Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
    Petricević J; Petković M; Jonjić N
    Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of premenopausal women with early-stage breast cancer: is there a role for ovarian suppression?
    Baum M; O'Shaughnessy JA
    Clin Breast Cancer; 2002 Oct; 3(4):260-7. PubMed ID: 12425754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.